We have been extensively involved in the research and development of innovative drugs in the fields of central nervous system diseases, cardiovascular and cerebrovascular diseases, refractory solid tumors, allergic respiratory diseases, and other disease areas for many years. Currently, we are rapidly advancing with multiple IND filings for innovative drugs every year, accumulating rich practical experience and technological assets.

We intend to transfer or license some of our high-value technological assets. We welcome inquiries and discussions from global pharmaceutical research and development companies, as well as pharmaceutical manufacturing companies.